OBJECTIVES: We seek to identify and analyze, from a group of participants experienced with HIV screening, the perceived challenges and solutions to the ethical, financial, and legal considerations of emergency department (ED)-based HIV screening. METHODS: We performed a qualitative analysis of the focus group discussions from the ethical, financial, and legal considerations portion of the inaugural National Emergency Department HIV Testing Consortium conference. Four groups composed of 20 to 25 consortium participants engaged in semistructured, facilitated focus group discussions. The focus group discussions were audiotaped and transcribed. A primary reader identified major themes and subthemes and representative quotes from the transcripts and summarized the discussions. Secondary and tertiary readers reviewed the themes, subthemes, and summaries for accuracy. RESULTS: The focus group discussions centered on the following themes. Ethical considerations included appropriateness of HIV screening in the ED and ethics of key elements of the 2006 Centers for Disease Control and Prevention HIV testing recommendations. Financial considerations included models of payment and support, role of health care insurance, financial ethics and downstream financial burdens, and advocacy approaches. Legal considerations included the adequacy of obtaining consent, partner notification, disclosure of HIV results, difficulties in addressing special populations, failure of not performing universal screening, failure to notify a person of being tested, failure to notify someone of their test results, liability of inaccurate tests, and failure to link to care. CONCLUSION: This qualitative analysis provides a broadly useful foundation to the ethical, financial, and legal considerations of implementing HIV screening programs in EDs throughout the United States.
OBJECTIVES: We seek to identify and analyze, from a group of participants experienced with HIV screening, the perceived challenges and solutions to the ethical, financial, and legal considerations of emergency department (ED)-based HIV screening. METHODS: We performed a qualitative analysis of the focus group discussions from the ethical, financial, and legal considerations portion of the inaugural National Emergency Department HIV Testing Consortium conference. Four groups composed of 20 to 25 consortium participants engaged in semistructured, facilitated focus group discussions. The focus group discussions were audiotaped and transcribed. A primary reader identified major themes and subthemes and representative quotes from the transcripts and summarized the discussions. Secondary and tertiary readers reviewed the themes, subthemes, and summaries for accuracy. RESULTS: The focus group discussions centered on the following themes. Ethical considerations included appropriateness of HIV screening in the ED and ethics of key elements of the 2006 Centers for Disease Control and Prevention HIV testing recommendations. Financial considerations included models of payment and support, role of health care insurance, financial ethics and downstream financial burdens, and advocacy approaches. Legal considerations included the adequacy of obtaining consent, partner notification, disclosure of HIV results, difficulties in addressing special populations, failure of not performing universal screening, failure to notify a person of being tested, failure to notify someone of their test results, liability of inaccurate tests, and failure to link to care. CONCLUSION: This qualitative analysis provides a broadly useful foundation to the ethical, financial, and legal considerations of implementing HIV screening programs in EDs throughout the United States.
Authors: Michael J Waxman; Roland C Merchant; Daniel A O'Connell; Abigail Gallucci; Lisa Sutton; Ashar Ata; Ethan A Cowan; Douglas Fish Journal: Public Health Rep Date: 2017-01-31 Impact factor: 2.792
Authors: Jason S Haukoos; Emily Hopkins; Meggan M Bucossi; Michael S Lyons; Richard E Rothman; Douglas A E White; Alia A Al-Tayyib; Lucy Bradley-Springer; Jonathan D Campbell; Allison L Sabel; Mark W Thrun Journal: J Acquir Immune Defic Syndr Date: 2015-04-15 Impact factor: 3.731
Authors: James W Galbraith; James H Willig; Joel B Rodgers; John P Donnelly; Andrew O Westfall; Kelly L Ross-Davis; Sonya L Heath Journal: Public Health Rep Date: 2016 Jan-Feb Impact factor: 2.792
Authors: Brittney Copeland; Bijal Shah; Matthew Wheatley; Katherine Heilpern; Carlos del Rio; Debra Houry Journal: AIDS Patient Care STDS Date: 2012-02-22 Impact factor: 5.078
Authors: Stacey A Rizza; Robin J MacGowan; David W Purcell; Bernard M Branson; Zelalem Temesgen Journal: Mayo Clin Proc Date: 2012-09 Impact factor: 7.616
Authors: Michael J Waxman; Maile Ray; Elissa M Schechter-Perkins; Kiran Faryar; Karen Coen Flynn; Mandi Breen; Susan M Wojcik; Fiona Berry; Amy Zheng; Ashar Ata; E Brooke Lerner; Michael S Lyons; Sandra McGinnis Journal: Public Health Rep Date: 2022-04-23 Impact factor: 3.117
Authors: Madeleine Whalen; Pamela Mda; Andy Parrish; Thomas C Quinn; Richard Rothman; David Stead; Bhakti Hansoti Journal: South Afr J HIV Med Date: 2018-07-16 Impact factor: 2.744